BACKGROUND:Tobacco dependence disorder is a chronic relapsing condition, yet treatment is delivered in discrete episodes of care that yield disappointing long-term quit rates. METHODS: We conducted a randomized controlled trial from June 1, 2004, through May 31, 2009, to compare telephone-based chronic disease management (1 year; longitudinal care [LC]) with evidence-based treatment (8 weeks; usual care [UC]) for tobacco dependence. A total of 443 smokers each received 5telephone counseling calls and nicotine replacement therapy by mail for 4 weeks. They were then randomized to UC (2 additional calls) or LC (continued counseling and nicotine replacement therapy for an additional 48 weeks). Longitudinal care targeted repeat quit attempts and interim smoking reduction for relapsers. The primary outcome was 6 months of prolonged abstinence measured at 18 months of follow-up. RESULTS: At 18 months, 30.2% of LC participants reported 6 months of abstinence from smoking, compared with 23.5% in UC (unadjusted, P = .13). Multivariate analysis showed that LC (adjusted odds ratio, 1.74; 95% CI, 1.08-2.80), quit attempts in past year (1.75; 1.06-2.89), baseline cigarettes per day (0.95; 0.92-0.99), and smoking in the 14- to 21-day interval post-quit (0.23; 0.14-0.38) predicted prolonged abstinence at 18 months. The LC participants who did not quit reduced smoking more than UC participants (significant only at 12 months). The LC participants received more counseling calls than UC participants (mean, 16.5 vs 5.8 calls; P < .001), longer total duration of counseling (283 vs 117 minutes; P < .001), and more nicotine replacement therapy (4.7 vs 2.4 boxes of patches; P < .001). CONCLUSION: A chronic disease management approach increases both short- and long-term abstinence from smoking. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00309296.
RCT Entities:
BACKGROUND:Tobacco dependence disorder is a chronic relapsing condition, yet treatment is delivered in discrete episodes of care that yield disappointing long-term quit rates. METHODS: We conducted a randomized controlled trial from June 1, 2004, through May 31, 2009, to compare telephone-based chronic disease management (1 year; longitudinal care [LC]) with evidence-based treatment (8 weeks; usual care [UC]) for tobacco dependence. A total of 443 smokers each received 5 telephone counseling calls and nicotine replacement therapy by mail for 4 weeks. They were then randomized to UC (2 additional calls) or LC (continued counseling and nicotine replacement therapy for an additional 48 weeks). Longitudinal care targeted repeat quit attempts and interim smoking reduction for relapsers. The primary outcome was 6 months of prolonged abstinence measured at 18 months of follow-up. RESULTS: At 18 months, 30.2% of LC participants reported 6 months of abstinence from smoking, compared with 23.5% in UC (unadjusted, P = .13). Multivariate analysis showed that LC (adjusted odds ratio, 1.74; 95% CI, 1.08-2.80), quit attempts in past year (1.75; 1.06-2.89), baseline cigarettes per day (0.95; 0.92-0.99), and smoking in the 14- to 21-day interval post-quit (0.23; 0.14-0.38) predicted prolonged abstinence at 18 months. The LC participants who did not quit reduced smoking more than UC participants (significant only at 12 months). The LC participants received more counseling calls than UC participants (mean, 16.5 vs 5.8 calls; P < .001), longer total duration of counseling (283 vs 117 minutes; P < .001), and more nicotine replacement therapy (4.7 vs 2.4 boxes of patches; P < .001). CONCLUSION: A chronic disease management approach increases both short- and long-term abstinence from smoking. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00309296.
Authors: Robert A Schnoll; Freda Patterson; E Paul Wileyto; Daniel F Heitjan; Alexandra E Shields; David A Asch; Caryn Lerman Journal: Ann Intern Med Date: 2010-02-02 Impact factor: 25.391
Authors: Sharon M Hall; Gary L Humfleet; Ricardo F Muñoz; Victor I Reus; Julie A Robbins; Judith J Prochaska Journal: Addiction Date: 2009-04-09 Impact factor: 6.526
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Edward F Ellerbeck; Jonathan D Mahnken; A Paula Cupertino; Lisa Sanderson Cox; K Allen Greiner; Laura M Mussulman; Niaman Nazir; Theresa I Shireman; Kenneth Resnicow; Jasjit S Ahluwalia Journal: Ann Intern Med Date: 2009-04-07 Impact factor: 25.391
Authors: Ralph S Caraballo; Judy Kruger; Kat Asman; Linda Pederson; Rachel Widome; Catarina I Kiefe; Brian Hitsman; David R Jacobs Journal: Addict Behav Date: 2013-09-16 Impact factor: 3.913
Authors: Bryan W Heckman; K Michael Cummings; Karin A Kasza; Ron Borland; Jessica L Burris; Geoffrey T Fong; Ann McNeill; Matthew J Carpenter Journal: Am J Prev Med Date: 2017-03-20 Impact factor: 5.043
Authors: Richard Saitz; Debbie M Cheng; Michael Winter; Theresa W Kim; Seville M Meli; Don Allensworth-Davies; Christine A Lloyd-Travaglini; Jeffrey H Samet Journal: JAMA Date: 2013-09-18 Impact factor: 56.272
Authors: Francisco I Salgado García; Karen J Derefinko; Zoran Bursac; Sarah Hand; Robert C Klesges Journal: Contemp Clin Trials Date: 2018-03-13 Impact factor: 2.226
Authors: Tatiane da S Campos; Kimber P Richter; A Paula Cupertino; Arise G S Galil; Eliane F C Banhato; Fernando A B Colugnati; Marcus G Bastos Journal: Int J Cardiol Date: 2014-04-22 Impact factor: 4.164